SNCA and Parkinson disease: Finally, the impact of estradiol in the synthesis, release, reuptake, and turnover of dopamine has been demonstrated in animal models of PD [52], thus explaining the potential protective effect of estrogens in dopaminergic neurons with possible inhibitory effects on the formation and stabilization of α-synuclein fibrils [61].